BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01714739-completion@plaintrial.com
DTSTAMP:20261029T034603Z
DTSTART;VALUE=DATE:20191213
SUMMARY:A Study of an Anti-KIR Antibody Lirilumab in Combination With an An
 ti-PD1 Antibody Nivolumab and Nivolumab Plus an Anti-CTLA-4 Ipilimumab Ant
 ibody in Patients With Advanced Solid Tumors — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01714739
URL:https://plaintrial.com/trial/NCT01714739
END:VEVENT
END:VCALENDAR